Fund profile
Tickers
BIPIX, BIPSX
Fund manager
Total assets
$107.90 mm
Liabilities
$1.47 mm
Net assets
$106.44 mm
Number of holdings
128.00
128 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
SOCIETE GENERALE | 8.59 mm | 8.59 mm principal | 8.07 | Repurchase agreement | Long | USA |
HSBC SECURITIES USA INC | 5.15 mm | 5.15 mm principal | 4.84 | Repurchase agreement | Long | USA |
CREDIT AGRICOLE CIB NY | 4.29 mm | 4.29 mm principal | 4.03 | Repurchase agreement | Long | USA |
Natwest Markets PLC | 3.58 mm | 3.58 mm principal | 3.36 | Repurchase agreement | Long | USA |
ROYAL BANK OF CANADA | 3.58 mm | 3.58 mm principal | 3.36 | Repurchase agreement | Long | USA |
UMB FINANCIAL CORP | 2.72 mm | 2.72 mm principal | 2.56 | Repurchase agreement | Long | USA |
CYTK Cytokinetics Inc | 2.19 mm | 28.01 k shares | 2.06 | Common equity | Long | USA |
KRTX Karuna Therapeutics Inc | 1.46 mm | 4.65 k shares | 1.37 | Common equity | Long | USA |
SRPT Sarepta Therapeutics Inc | 1.31 mm | 10.98 k shares | 1.23 | Common equity | Long | USA |
Invesco Government & Agency Portfolio | 1.30 mm | 1.30 mm shares | 1.22 | Short-term investment vehicle | N/A | USA |
BHVN Biohaven Ltd. | 1.29 mm | 28.89 k shares | 1.21 | Common equity | Long | Virgin Islands (British) |
ARDX Ardelyx Inc | 1.28 mm | 146.34 k shares | 1.20 | Common equity | Long | USA |
ARWR Arrowhead Pharmaceuticals Inc. | 1.25 mm | 38.84 k shares | 1.17 | Common equity | Long | USA |
MRNA Moderna Inc | 1.21 mm | 11.96 k shares | 1.14 | Common equity | Long | USA |
PCVX Vaxcyte Inc | 1.20 mm | 16.86 k shares | 1.13 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals, Inc. | 1.18 mm | 2.73 k shares | 1.11 | Common equity | Long | USA |
ACAD Acadia Pharmaceuticals Inc | 1.18 mm | 45.53 k shares | 1.11 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 1.14 mm | 8.14 k shares | 1.07 | Common equity | Long | USA |
AMGN AMGEN Inc. | 1.12 mm | 3.55 k shares | 1.05 | Common equity | Long | USA |
NTRA Natera Inc | 1.08 mm | 16.43 k shares | 1.02 | Common equity | Long | USA |
RVMD Revolution Medicines Inc | 1.08 mm | 38.85 k shares | 1.01 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 1.07 mm | 1.14 k shares | 1.01 | Common equity | Long | USA |
VKTX Viking Therapeutics Inc | 1.06 mm | 43.97 k shares | 1.00 | Common equity | Long | USA |
IRWD Ironwood Pharmaceuticals Inc - Ordinary Shares | 1.06 mm | 74.66 k shares | 1.00 | Common equity | Long | USA |
ABBV Abbvie Inc | 1.05 mm | 6.40 k shares | 0.99 | Common equity | Long | USA |
FOLD Amicus Therapeutics Inc | 1.05 mm | 84.62 k shares | 0.99 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 1.04 mm | 23.61 k shares | 0.98 | Common equity | Long | USA |
AKRO Akero Therapeutics Inc | 1.04 mm | 48.07 k shares | 0.98 | Common equity | Long | USA |
BPMC Blueprint Medicines Corp | 1.03 mm | 12.91 k shares | 0.96 | Common equity | Long | USA |
INCY Incyte Corp. | 1.03 mm | 17.46 k shares | 0.96 | Common equity | Long | USA |
IOVA Iovance Biotherapeutics Inc | 1.03 mm | 132.73 k shares | 0.96 | Common equity | Long | USA |
NUVL Nuvalent Inc - Ordinary Shares | 1.02 mm | 13.52 k shares | 0.95 | Common equity | Long | USA |
RXRX Recursion Pharmaceuticals Inc - Ordinary Shares | 1.01 mm | 107.41 k shares | 0.95 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals Inc | 1.01 mm | 19.60 k shares | 0.95 | Common equity | Long | USA |
BBIO BridgeBio Pharma Inc | 1.01 mm | 29.37 k shares | 0.95 | Common equity | Long | USA |
ALKS Alkermes plc | 998.42 k | 36.91 k shares | 0.94 | Common equity | Long | Ireland |
KRYS Krystal Biotech Inc | 994.46 k | 8.94 k shares | 0.93 | Common equity | Long | USA |
MDGL Madrigal Pharmaceuticals Inc | 993.62 k | 4.59 k shares | 0.93 | Common equity | Long | USA |
TGTX TG Therapeutics Inc | 986.77 k | 60.76 k shares | 0.93 | Common equity | Long | USA |
BIIB Biogen Inc | 984.67 k | 3.99 k shares | 0.93 | Common equity | Long | USA |
ROIV Roivant Sciences Ltd | 971.69 k | 97.17 k shares | 0.91 | Common equity | Long | Bermuda |
ALNY Alnylam Pharmaceuticals Inc | 971.24 k | 5.62 k shares | 0.91 | Common equity | Long | USA |
EXAS Exact Sciences Corp. | 966.15 k | 14.77 k shares | 0.91 | Common equity | Long | USA |
APLS Apellis Pharmaceuticals Inc | 962.58 k | 15.21 k shares | 0.90 | Common equity | Long | USA |
IMGN Immunogen, Inc. | 958.82 k | 32.70 k shares | 0.90 | Common equity | Long | USA |
INSM Insmed Inc | 949.70 k | 34.16 k shares | 0.89 | Common equity | Long | USA |
CRNX Crinetics Pharmaceuticals Inc | 948.15 k | 25.99 k shares | 0.89 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 946.01 k | 12.09 k shares | 0.89 | Common equity | Long | USA |
EXEL Exelixis Inc | 944.78 k | 43.42 k shares | 0.89 | Common equity | Long | USA |
PTCT PTC Therapeutics Inc | 943.36 k | 36.16 k shares | 0.89 | Common equity | Long | USA |
CRSP CRISPR Therapeutics AG | 931.72 k | 14.80 k shares | 0.88 | Common equity | Long | Switzerland |
BMRN Biomarin Pharmaceutical Inc. - Registered Shares | 905.37 k | 10.28 k shares | 0.85 | Common equity | Long | USA |
IDYA Ideaya Biosciences Inc | 895.54 k | 20.57 k shares | 0.84 | Common equity | Long | USA |
IMVT Immunovant Inc | 887.42 k | 24.37 k shares | 0.83 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc | 881.89 k | 36.14 k shares | 0.83 | Common equity | Long | USA |
SNDX Syndax Pharmaceuticals Inc | 878.06 k | 42.85 k shares | 0.82 | Common equity | Long | USA |
UTHR United Therapeutics Corp | 849.03 k | 3.95 k shares | 0.80 | Common equity | Long | USA |
SAGE Sage Therapeutics Inc | 837.22 k | 32.65 k shares | 0.79 | Common equity | Long | USA |
HALO Halozyme Therapeutics Inc. | 809.32 k | 23.91 k shares | 0.76 | Common equity | Long | USA |
TWST Twist Bioscience Corp | 791.47 k | 24.43 k shares | 0.74 | Common equity | Long | USA |
NTLA Intellia Therapeutics Inc | 784.30 k | 32.93 k shares | 0.74 | Common equity | Long | USA |
DVAX Dynavax Technologies Corp. | 742.72 k | 57.49 k shares | 0.70 | Common equity | Long | USA |
ACLX Arcellx Inc | 736.51 k | 11.91 k shares | 0.69 | Common equity | Long | USA |
NVAX Novavax, Inc. | 685.94 k | 171.48 k shares | 0.64 | Common equity | Long | USA |
MORF Morphic Holding Inc | 683.52 k | 21.57 k shares | 0.64 | Common equity | Long | USA |
SWTX SpringWorks Therapeutics Inc | 678.63 k | 15.38 k shares | 0.64 | Common equity | Long | USA |
VERA Vera Therapeutics Inc - Ordinary Shares | 661.71 k | 18.17 k shares | 0.62 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals Inc | 638.21 k | 22.21 k shares | 0.60 | Common equity | Long | USA |
CERE Cerevel Therapeutics Holdings Inc | 630.72 k | 15.05 k shares | 0.59 | Common equity | Long | USA |
PRTA Prothena Corporation plc | 626.48 k | 22.07 k shares | 0.59 | Common equity | Long | Ireland |
RYTM Rhythm Pharmaceuticals Inc. | 572.28 k | 12.97 k shares | 0.54 | Common equity | Long | USA |
CLDX Celldex Therapeutics Inc. | 554.64 k | 15.75 k shares | 0.52 | Common equity | Long | USA |
DNLI Denali Therapeutics Inc | 548.41 k | 34.25 k shares | 0.52 | Common equity | Long | USA |
CPRX Catalyst Pharmaceuticals Inc | 539.55 k | 37.47 k shares | 0.51 | Common equity | Long | USA |
BCRX Biocryst Pharmaceuticals Inc. | 538.82 k | 101.66 k shares | 0.51 | Common equity | Long | USA |
VCEL Vericel Corp | 483.83 k | 11.26 k shares | 0.45 | Common equity | Long | USA |
ETNB 89bio Inc | 477.83 k | 48.27 k shares | 0.45 | Common equity | Long | USA |
CABA Cabaletta Bio Inc | 456.01 k | 22.27 k shares | 0.43 | Common equity | Long | USA |
ZNTL Zentalis Pharmaceuticals Inc | 454.02 k | 38.31 k shares | 0.43 | Common equity | Long | USA |
PTGX Protagonist Therapeutics Inc | 446.88 k | 17.87 k shares | 0.42 | Common equity | Long | USA |
VCYT Veracyte Inc | 424.51 k | 16.97 k shares | 0.40 | Common equity | Long | USA |
INBX Inhibrx Inc | 423.21 k | 10.98 k shares | 0.40 | Common equity | Long | USA |
KYMR Kymera Therapeutics Inc | 419.16 k | 12.79 k shares | 0.39 | Common equity | Long | USA |
VRDN Viridian Therapeutics Inc | 414.70 k | 21.54 k shares | 0.39 | Common equity | Long | USA |
TVTX Travere Therapeutics Inc | 407.71 k | 45.66 k shares | 0.38 | Common equity | Long | USA |
RCUS Arcus Biosciences Inc | 404.96 k | 26.75 k shares | 0.38 | Common equity | Long | USA |
VIR Vir Biotechnology Inc | 398.98 k | 42.45 k shares | 0.37 | Common equity | Long | USA |
Arcturus Therapeutics Holdings, Inc. | 396.96 k | 12.04 k shares | 0.37 | Common equity | Long | USA |
MYGN Myriad Genetics, Inc. | 389.88 k | 18.23 k shares | 0.37 | Common equity | Long | USA |
KROS Keros Therapeutics Inc | 384.48 k | 6.95 k shares | 0.36 | Common equity | Long | USA |
REPL Replimune Group Inc | 382.11 k | 49.24 k shares | 0.36 | Common equity | Long | USA |
DAWN Day One Biopharmaceuticals Inc | 378.46 k | 25.15 k shares | 0.36 | Common equity | Long | USA |
DYN Dyne Therapeutics Inc | 373.45 k | 17.45 k shares | 0.35 | Common equity | Long | USA |
AGIO Agios Pharmaceuticals Inc | 369.23 k | 16.32 k shares | 0.35 | Common equity | Long | USA |
MIRM Mirum Pharmaceuticals Inc | 366.95 k | 13.87 k shares | 0.34 | Common equity | Long | USA |
VERV Verve Therapeutics Inc | 351.07 k | 32.45 k shares | 0.33 | Common equity | Long | USA |
GERN Geron Corp. | 326.74 k | 177.58 k shares | 0.31 | Common equity | Long | USA |
KURA Kura Oncology Inc | 324.19 k | 16.10 k shares | 0.30 | Common equity | Long | USA |
RLAY Relay Therapeutics Inc | 323.30 k | 34.95 k shares | 0.30 | Common equity | Long | USA |
ADMA Adma Biologics Inc | 300.56 k | 57.91 k shares | 0.28 | Common equity | Long | USA |
MNKD Mannkind Corp | 290.36 k | 86.93 k shares | 0.27 | Common equity | Long | USA |
IRON Disc Medicine Inc | 278.85 k | 4.24 k shares | 0.26 | Common equity | Long | USA |
CDMO Avid Bioservices Inc | 274.54 k | 40.55 k shares | 0.26 | Common equity | Long | USA |
EDIT Editas Medicine Inc | 266.24 k | 37.87 k shares | 0.25 | Common equity | Long | USA |
IBRX ImmunityBio Inc | 264.46 k | 78.71 k shares | 0.25 | Common equity | Long | USA |
SLNO Soleno Therapeutics Inc | 255.85 k | 5.52 k shares | 0.24 | Common equity | Long | USA |
RNA Avidity Biosciences Inc | 255.33 k | 20.88 k shares | 0.24 | Common equity | Long | USA |
SANA Sana Biotechnology Inc | 253.08 k | 46.10 k shares | 0.24 | Common equity | Long | USA |
CRBU Caribou Biosciences Inc | 249.01 k | 40.62 k shares | 0.23 | Common equity | Long | USA |
RAPT RAPT Therapeutics Inc | 241.11 k | 9.74 k shares | 0.23 | Common equity | Long | USA |
XNCR Xencor Inc | 238.39 k | 12.75 k shares | 0.22 | Common equity | Long | USA |
ALPN Alpine Immune Sciences Inc | 226.93 k | 8.53 k shares | 0.21 | Common equity | Long | USA |
QURE uniQure N.V. | 218.14 k | 39.23 k shares | 0.20 | Common equity | Long | Netherlands |
DCPH Deciphera Pharmaceuticals Inc | 212.68 k | 14.85 k shares | 0.20 | Common equity | Long | USA |
BMEA Biomea Fusion Inc | 195.59 k | 10.82 k shares | 0.18 | Common equity | Long | USA |
KNSA Kiniksa Pharmaceuticals Ltd - Ordinary Shares | 179.81 k | 10.20 k shares | 0.17 | Common equity | Long | Bermuda |
CDNA Caredx Inc | 173.41 k | 20.26 k shares | 0.16 | Common equity | Long | USA |
SRRK Scholar Rock Holding Corp | 159.85 k | 11.46 k shares | 0.15 | Common equity | Long | USA |
RGNX Regenxbio Inc | 157.99 k | 12.82 k shares | 0.15 | Common equity | Long | USA |
FDMT 4D Molecular Therapeutics Inc | 156.84 k | 9.09 k shares | 0.15 | Common equity | Long | USA |
MDXG Mimedx Group Inc | 149.61 k | 19.33 k shares | 0.14 | Common equity | Long | USA |
AVXL Anavex Life Sciences Corporation | 147.38 k | 24.69 k shares | 0.14 | Common equity | Long | USA |
MGNX Macrogenics Inc | 144.12 k | 10.08 k shares | 0.14 | Common equity | Long | USA |
BLUE Bluebird bio Inc | 141.56 k | 138.79 k shares | 0.13 | Common equity | Long | USA |
COGT Cogent Biosciences Inc | 136.06 k | 30.71 k shares | 0.13 | Common equity | Long | USA |
ALEC Alector Inc | 121.05 k | 20.31 k shares | 0.11 | Common equity | Long | USA |
TOTAL RETURN SWAP AGREEMENT BASED ON THE DOW JONES U.S. BIOTECHNOLOGY INDEX
GOLDMAN SACHS GROUP, INC
|
-921.87 k | 5.73 k other units | -0.87 | Equity derivative | N/A | USA |
TOTAL RETURN SWAP AGREEMENT BASED ON THE DOW JONES U.S. BIOTECHNOLOGY INDEX
UBS SECURITIES LLC
|
-944.03 k | 5.91 k other units | -0.89 | Equity derivative | N/A | USA |